{"id":"https://openalex.org/W4308385284","doi":"https://doi.org/10.1136/jitc-2022-sitc2022.1132","title":"1132 Impact of intralesional oncolytic viral therapy targeting in situ activation of CD40 and type 1 interferon signaling pathways on the TME and systemic T cell immunity in murine models and cancer patients","display_name":"1132 Impact of intralesional oncolytic viral therapy targeting in situ activation of CD40 and type 1 interferon signaling pathways on the TME and systemic T cell immunity in murine models and cancer patients","publication_year":2022,"publication_date":"2022-11-01","ids":{"openalex":"https://openalex.org/W4308385284","doi":"https://doi.org/10.1136/jitc-2022-sitc2022.1132"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2022-sitc2022.1132","doi":"https://doi.org/10.1136/jitc-2022-sitc2022.1132","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2022-sitc2022.1132","pdf_url":"https://jitc.bmj.com/content/jitc/10/Suppl_2/A1176.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/jitc/10/Suppl_2/A1176.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5054228821","display_name":"Andreas Nicholas Saltos","orcid":"https://orcid.org/0000-0003-3622-026X","observed_orcids":["https://orcid.org/0000-0003-3622-026X"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andreas Saltos","raw_affiliation_strings":["Moffitt Cancer Center, Tampa, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moffitt Cancer Center, Tampa, FL, USA","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Hong Zheng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hong Zheng","raw_affiliation_strings":["Moffitt Cancer Center, Tampa, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moffitt Cancer Center, Tampa, FL, USA","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113878292","display_name":"Christy Arrowood","orcid":"https://orcid.org/0009-0000-3263-9659","observed_orcids":["https://orcid.org/0009-0000-3263-9659"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christy Arrowood","raw_affiliation_strings":["Duke University, Durham, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University, Durham, NC, USA","institution_ids":["https://openalex.org/I170897317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050528758","display_name":"Georgia Marie Beasley","orcid":"https://orcid.org/0000-0001-6387-9030","observed_orcids":["https://orcid.org/0000-0001-6387-9030"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Georgia Beasley","raw_affiliation_strings":["Duke University, Durham, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University, Durham, NC, USA","institution_ids":["https://openalex.org/I170897317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018234323","display_name":"James Ronald","orcid":"https://orcid.org/0000-0002-2959-4354","observed_orcids":["https://orcid.org/0000-0002-2959-4354"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James Ronald","raw_affiliation_strings":["Duke University, Durham, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University, Durham, NC, USA","institution_ids":["https://openalex.org/I170897317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075077546","display_name":"Ghassan E. El-Haddad","orcid":"https://orcid.org/0000-0003-1149-263X","observed_orcids":["https://orcid.org/0000-0003-1149-263X"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ghassan El-Haddad","raw_affiliation_strings":["Moffitt Cancer Center, Tampa, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moffitt Cancer Center, Tampa, FL, USA","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Uzma Khan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Uzma Khan","raw_affiliation_strings":["Duke University, Durham, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University, Durham, NC, USA","institution_ids":["https://openalex.org/I170897317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001062982","display_name":"Luiziane Guerra-Guevara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Luiziane Guerra-Guevara","raw_affiliation_strings":["Moffitt Cancer Center, Tampa, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moffitt Cancer Center, Tampa, FL, USA","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Steven Wolf","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven Wolf","raw_affiliation_strings":["Duke University, Durham, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University, Durham, NC, USA","institution_ids":["https://openalex.org/I170897317"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Lin Gu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lin Gu","raw_affiliation_strings":["Duke University, Durham, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University, Durham, NC, USA","institution_ids":["https://openalex.org/I170897317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100363449","display_name":"Xiaofei Wang","orcid":"https://orcid.org/0000-0001-7512-8445","observed_orcids":["https://orcid.org/0000-0001-7512-8445"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiaofei Wang","raw_affiliation_strings":["Duke University, Durham, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University, Durham, NC, USA","institution_ids":["https://openalex.org/I170897317"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Mark Cantwell","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark Cantwell","raw_affiliation_strings":["Memgen, Inc, Meadow Vista, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memgen, Inc, Meadow Vista, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046273815","display_name":"Scott Joseph Antonia","orcid":"https://orcid.org/0000-0002-6686-3824","observed_orcids":["https://orcid.org/0000-0002-6686-3824"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott Antonia","raw_affiliation_strings":["Duke University, Durham, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University, Durham, NC, USA","institution_ids":["https://openalex.org/I170897317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032171890","display_name":"Amer A. Beg","orcid":"https://orcid.org/0000-0003-3834-774X","observed_orcids":["https://orcid.org/0000-0003-3834-774X"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amer Beg","raw_affiliation_strings":["Moffitt Cancer Center, Tampa, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moffitt Cancer Center, Tampa, FL, USA","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5079438136","display_name":"Neal Ready","orcid":"https://orcid.org/0000-0003-4414-9432","observed_orcids":["https://orcid.org/0000-0003-4414-9432"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neal Ready","raw_affiliation_strings":["Duke University, Durham, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University, Durham, NC, USA","institution_ids":["https://openalex.org/I170897317"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A1176","last_page":"A1176"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.7318999767303467,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.7318999767303467,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.26269999146461487,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0026000000070780516,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/oncolytic-virotherapy","display_name":"oncolytic virotherapy","score":0.9110000133514404},{"id":"https://openalex.org/keywords/cd40-ligand","display_name":"CD40 ligand","score":0.7580000162124634},{"id":"https://openalex.org/keywords/interferon-beta","display_name":"interferon-beta","score":0.9480000138282776},{"id":"https://openalex.org/keywords/myeloid-dendritic-cells","display_name":"myeloid dendritic cells","score":0.7039999961853027},{"id":"https://openalex.org/keywords/type-i-interferon-signaling","display_name":"type I interferon signaling","score":0.8659999966621399},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.8870000243186951},{"id":"https://openalex.org/keywords/cd8-t-cell-responses","display_name":"CD8+ T cell responses","score":0.8140000104904175},{"id":"https://openalex.org/keywords/t-cell-exhaustion","display_name":"T cell exhaustion","score":0.546999990940094},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.8109999895095825},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.8999999761581421},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.9169999957084656},{"id":"https://openalex.org/keywords/lung-metastasis","display_name":"lung metastasis","score":0.6269999742507935},{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.5600000023841858},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.3659999966621399},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.38499999046325684}],"concepts":[{"id":"https://openalex.org/C82210918","wikidata":"https://www.wikidata.org/wiki/Q1560099","display_name":"Oncolytic virus","level":3,"score":0.6986523866653442},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.5872294306755066},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5816291570663452},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.5485280156135559},{"id":"https://openalex.org/C2780380082","wikidata":"https://www.wikidata.org/wiki/Q12646460","display_name":"Granzyme B","level":4,"score":0.5241092443466187},{"id":"https://openalex.org/C2777283488","wikidata":"https://www.wikidata.org/wiki/Q7095181","display_name":"Oncolytic adenovirus","level":4,"score":0.49927377700805664},{"id":"https://openalex.org/C183193105","wikidata":"https://www.wikidata.org/wiki/Q425068","display_name":"Granzyme","level":5,"score":0.4736306071281433},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.47107329964637756},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.44715026021003723},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4173429012298584},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.41270118951797485},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.36564600467681885},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3526577949523926},{"id":"https://openalex.org/C2776062744","wikidata":"https://www.wikidata.org/wiki/Q21103279","display_name":"Perforin","level":4,"score":0.3263729214668274}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/jitc-2022-sitc2022.1132","doi":"https://doi.org/10.1136/jitc-2022-sitc2022.1132","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2022-sitc2022.1132","pdf_url":"https://jitc.bmj.com/content/jitc/10/Suppl_2/A1176.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2022-sitc2022.1132","doi":"https://doi.org/10.1136/jitc-2022-sitc2022.1132","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2022-sitc2022.1132","pdf_url":"https://jitc.bmj.com/content/jitc/10/Suppl_2/A1176.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4308385284.pdf","grobid_xml":"https://content.openalex.org/works/W4308385284.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4319656721","https://openalex.org/W4393092623","https://openalex.org/W3182275357","https://openalex.org/W4282961189","https://openalex.org/W4312139590","https://openalex.org/W4379283614","https://openalex.org/W4385330485","https://openalex.org/W4365513143","https://openalex.org/W4402507944","https://openalex.org/W3083070951"],"abstract_inverted_index":{"Background":[0],"Oncolytic":[1],"viral":[2,301],"therapies":[3],"are":[4,223,261,336],"thought":[5],"to":[6,79,95,172,225,231,248,329,398,418],"act":[7],"through":[8],"both":[9,207,350],"direct":[10],"killing":[11],"of":[12,17,57,63,75,112,115,189,206,251,288,295,306,346,375],"tumor":[13,87,137,309,355],"cells":[14,20,221,321,335],"and":[15,52,67,77,85,91,101,135,139,145,157,187,201,240,254,268,311,322,340,353,360,420],"activation":[16,31,165],"conventional":[18],"dendritic":[19],"(cDCs),":[21],"resulting":[22],"in":[23,82,117,123,159,170,176,192,304,317,349,364,392,421],"an":[24,124,379],"enhanced":[25,204],"T":[26,102,184,211,220,320,326,334],"cell":[27,185,212,276],"response.":[28],"However,":[29],"cDC":[30,164],"has":[32],"not":[33],"been":[34],"optimized":[35],"with":[36,119,229,238,245,314,389,394],"current":[37],"therapies.":[38],"MEM-288":[39,116,147,289,299,367,385],"is":[40,370,382],"a":[41,53,173,180,193],"conditionally-replicative":[42],"oncolytic":[43],"adenovirus":[44,243],"encoding":[45],"transgenes":[46],"for":[47,149,285],"human":[48],"interferon":[49],"beta":[50],"(IFN\u03b2)":[51],"recombinant":[54],"membrane-stable":[55],"form":[56],"CD40-ligand":[58],"(MEM40),":[59],"two":[60],"potent":[61],"activators":[62],"the":[64,109,264,272,307,347,365,376,422],"immune":[65,110,232,361],"response":[66,111,230,362],"cDCs.":[68,199],"Methods":[69],"We":[70],"evaluated":[71,284],"intralesional":[72,113,293],"adenoviral":[73],"delivery":[74],"MEM40":[76,156,200,239,339],"IFN\u03b2":[78,158,202,241,341],"activate":[80],"cDCs":[81,100],"mouse":[83],"melanoma":[84],"lung":[86,255,277],"models.":[88],"Flow":[89],"cytometry":[90],"scRNA-seq":[92],"were":[93,142,283],"used":[94],"determine":[96,330],"treatment":[97,148],"impact":[98,287],"on":[99,281,333],"cells.":[103,327],"Clinical":[104],"translational":[105],"research":[106],"also":[107,371],"investigated":[108],"administration":[114],"patients":[118,280,393],"select":[120],"solid":[121,354],"tumors":[122,191,253],"ongoing":[125,366],"Phase":[126],"1":[127,198],"dose-escalation,":[128],"multi-center,":[129],"open-label":[130],"trial":[131,369,424],"(NCT05076760).":[132],"Patient":[133],"pre-":[134],"on-treatment":[136,269],"biopsies":[138,270],"peripheral":[140],"blood":[141],"collected":[143],"before":[144,431],"after":[146],"immunologic":[150],"evaluation.":[151],"Results":[152],"In":[153],"preclinical":[154,259],"studies,":[155],"situ":[160],"co-expression":[161],"induced":[162],"higher":[163],"than":[166],"either":[167],"molecule":[168],"alone,":[169],"addition":[171],"dramatic":[174],"increase":[175],"lymph":[177],"node":[178],"migration,":[179],"systemic":[181,331],"anti-tumor":[182],"CD8+":[183,210,219,319,325],"response,":[186],"regression":[188],"established":[190],"manner":[194],"dependent":[195],"upon":[196],"type":[197],"expression":[203,342],"generation":[205],"Granzyme":[208],"B+":[209],"effectors":[213],"as":[214,216],"well":[215],"TCF1+":[217,323],"stem-like":[218,324],"that":[222],"known":[224],"be":[226,387],"strongly":[227],"associated":[228],"checkpoint":[233],"inhibitors":[234],"(ICIs).":[235],"Intralesional":[236],"therapy":[237],"expressing":[242],"synergized":[244],"ICIs,":[246],"leading":[247],"effective":[249],"control":[250],"distant":[252],"metastases.":[256],"Notably,":[257],"these":[258],"results":[260],"translating":[262],"into":[263],"clinical":[265,368,423],"setting.":[266],"Pre-":[267],"from":[271],"initial":[273],"2":[274],"non-small":[275],"cancer":[278],"(NSCLC)":[279],"study":[282],"TME":[286,348],"treatment.":[290],"A":[291],"single":[292],"injection":[294],"low":[296],"dose":[297],"cohort":[298],"(1e10":[300],"particles)":[302],"resulted":[303],"shrinkage":[305],"injected":[308],"(-31":[310],"-53%),":[312],"concomitant":[313],"substantial":[315],"increases":[316],"overall":[318],"Studies":[328],"effects":[332],"ongoing.":[337],"Conclusions":[338],"induces":[343],"strong":[344],"remodeling":[345],"murine":[351],"models":[352],"patients.":[356],"Preliminary":[357],"safety,":[358],"antitumor,":[359],"data":[363],"encouraging.":[372],"Following":[373],"completion":[374],"monotherapy":[377],"study,":[378],"expansion":[380],"arm":[381],"planned":[383],"where":[384],"will":[386],"combined":[388],"anti-PD1":[390],"antibody":[391],"advanced":[395],"NSCLC":[396],"refractory":[397],"ICI.":[399],"Ethics":[400],"Approval":[401],"The":[402],"studies":[403],"described":[404,425],"received":[405],"IRB":[406],"approval":[407],"(Moffitt:":[408],"Adverra":[409],"IRB,":[410,415],"#":[411],"Pro00060205,":[412],"Duke:":[413],"DUHS":[414],"#Pro00109517)":[416],"prior":[417],"commencement,":[419],"all":[426],"participants":[427],"gave":[428],"informed":[429],"consent":[430],"taking":[432],"part.":[433]},"counts_by_year":[],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2022-11-11T00:00:00"}